The Latest Cardiac and Vascular News
Internationally, the signing of licensing or distribution partnerships with major players in nutrition and healthcare. In France, Valbiotis has chosen to internalize its commercial operations for direct distribution, in order to generate rapid turnover and to ensure an independent and value-creating source of income. Continued structuring and R&D efforts on […]
GUILFORD, Conn., Oct. 06, 2022 (GLOBE NEWSWIRE) — Hyperfine, Inc. (Nasdaq: HYPR), (“Hyperfine” or “the Company”), the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI system™, today announced that it has named medical device industry veteran Maria Sainz as President and Chief Executive Officer (CEO) […]
The Company filed a 510(k) premarket notification for its prescription-only medical device to be used in-home for babies under the supervision of a physician LEHI, Utah–(BUSINESS WIRE)–Owlet, Inc. (NYSE: OWLT) (the “Company”) announces that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (“FDA”) for […]
Fiscal Year 2023 First Quarter Highlights Net sales of $81.5 million increased 5.9% compared to the prior-year quarter Med Tech net sales of $22.8 million increased 29.6% Med Device net sales of $58.7 million decreased 1.1% Gross margin of 51.9% declined 20 basis points year over year GAAP loss per […]
Leverages HeartBeam AIMIGo™ Platform to Address the Multibillion-Dollar Global Market for Detection of Atrial Arrhythmias SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced today the expansion of its product portfolio pipeline […]
PLANO, Texas, Oct. 05, 2022 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource manufacturer, provides a revised 2022 outlook and an update on the third quarter. Integer’s customer demand continues to be very strong from end-market growth and the execution of the company’s growth strategies, […]
KFAR-SABA, Israel and IRVINE, Calif., Oct. 6, 2022 /PRNewswire/ — CathWorks announced today the approval of the fourth generation CathWorks FFRangio® System by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). The FFRangio System is also commercially available in the United States and Europe. “The FFRangio System enables us to quickly perform a comprehensive physiologic assessment of coronary artery […]
OAKVILLE, ON, Oct. 6, 2022 /PRNewswire/ – CHS USA Inc., a company of Canadian Hospital Specialties Limited (CHS), completed the acquisition of Medical Imaging Solutions International. (“MISI”), effective September 16th, 2022. This acquisition will further increase CHS’ presence in the United States diagnostic imaging market. MISI and CHS are known in the healthcare industry for high quality and […]
RANCHO CUCAMONGA, Calif., Oct. 6, 2022 /PRNewswire/ — After treatment and discharge from the emergency room (ER) for congestive heart failure complications, Inland Empire Health Plan (IEHP) member Lavinia experienced panic and anxiety attacks that compounded her heart issues and led to more hospital visits. IEHP team members identified Lavinia’s specialized needs […]
PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products that act directly on the brain to treat resistant/difficult to treat hypertension and heart-failure, today announces the publication of an initiation report by Bryan […]
